MINNEAPOLIS – Two panel discussions during the 10th annual MedTech Investing Conference fit together so well that's it's a wonder they weren't scheduled this close together on the agenda, rather than having a couple of unrelated topics take the attendees in different directions, at least for a while. (Medical Device Daily)

MINNEAPOLIS – Saying that there's a funding gap for entrepreneur-driven, potentially innovative medical technology companies isn't news. News outlets covering both med-tech and the venture capital business – this publication certainly among them – have been carrying that message for two going on three years now. (Medical Device Daily)

Rick Randall has served as CEO of some of America's most innovative young medical-products companies, so when he talks about the positive vibes he's receiving from the clinical community about his latest company, Avantis Medical Systems (Sunnyvale, California), it's worth a listen. (Medical Device Daily)

 By most objective accounts, Donald Berwick is doing a pretty decent job as chief administrator of the Centers for Medicare & Medicaid Services, giving CMS a much-needed shot in the arm and kick in the . . . well, you know. Unfortunately, that appears to not be enough for him to keep the job beyond the end of the year, as mandated by law for "recess" appointments such as himself. Berwick, who knows the provider side of medicine as a pediatrician, is a health policy expert of some repute. He has been quite the thinker on broader healthcare questions, including...

Armed with the positive results of an external validation study that were unveiled during a conference in San Francisco earlier this year, Everist Genomics (Ann Arbor, Michigan) has reported the worldwide commercial availability of its OncoDefender-CRC colorectal cancer assay. (Medical Device Daily)

A young Texas company that is the result of a unique partnership involving a gigantic global maker of consumer electronics has received FDA approval to sell its ultrasound-based system for the early detection of heart disease, with sales having begun immediately upon receipt of the agency's go-ahead last week. (Medical Device Daily)